Guobang Pharma Ltd Cash Flow Quality Index
Guobang Pharma Ltd cash flow quality index. Guobang Pharma Ltd (605507) has a Cash Flow Quality Index of 1.45x as of September 2025. Operating cash flow of CN¥311.27 Million exceeds net income of CN¥214.67 Million, indicating high earnings quality where cash backs reported profits. See Guobang Pharma Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Guobang Pharma Ltd (2017–2025)
Cash flow quality index of Guobang Pharma Ltd from 2017 to 2025. Historical Cash Flow Quality Index for Guobang Pharma Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Guobang Pharma Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Guobang Pharma Ltd Cash Flow Quality Index by Year (2017–2025)
Guobang Pharma Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Guobang Pharma Ltd. For the full cash flow conversion analysis, see Guobang Pharma Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥559.28 Million | CN¥820.82 Million | ▼ -24.7% |
| 2024 | 0.90x | CN¥706.41 Million | CN¥780.58 Million | ▲ +7.3% |
| 2023 | 0.84x | CN¥516.76 Million | CN¥612.46 Million | ▼ -23.6% |
| 2022 | 1.10x | CN¥1.02 Billion | CN¥920.62 Million | ▲ +542.8% |
| 2021 | -0.25x | CN¥-176.18 Million | CN¥706.23 Million | ▼ -126.3% |
| 2020 | 0.95x | CN¥767.70 Million | CN¥810.29 Million | ▲ +6.2% |
| 2019 | 0.89x | CN¥440.86 Million | CN¥494.01 Million | ▼ -20.4% |
| 2018 | 1.12x | CN¥541.68 Million | CN¥483.46 Million | ▲ +196.1% |
| 2017 | 0.38x | CN¥148.03 Million | CN¥391.25 Million | — |